Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 4/20 | 0.53 |
| ▸ | NTSR1 | P30989 | 7/20 | 0.51 |
| ▸ | APLNR | P35414 | 1/20 | 0.51 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.51 |
| ▸ | NTSR2 | O95665 | 4/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.48 |
| ▸ | GLP1R | P43220 | 1/20 | 0.48 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.47 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.47 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.47 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.47 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.47 |
| ▸ | CALCR | P30988 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13234130 | 0.89 | AGTR1 (0.61) | AGTR1AGTR2 | |
| SCHEMBL13234135 | 0.88 | AGTR1 (0.59) | AGTR1AGTR2CALCR | |
| SCHEMBL13234131 | 0.88 | AGTR1 (0.59) | NTSR1AGTR1AGTR2CALCR | |
| SCHEMBL13234138 | 0.87 | AGTR1 (0.59) | AGTR1AGTR2 | |
| SCHEMBL13264037 | 0.85 | AGTR1 (0.56) | NTSR1AGTR1AGTR2CALCR | |
| SCHEMBL13197589 | 0.84 | AGTR1 (0.62) | AGTR1AGTR2CALCR | |
| SCHEMBL29973608 | 0.83 | C5AR1 (0.61) | F2NTSR1APLNRC5AR1NTSR2 | |
| SCHEMBL29359023 | 0.82 | AGTR2 (0.66) | F2NTSR1APLNRC5AR1NTSR2 | |
| SCHEMBL31544391 | 0.82 | AGTR1 (0.62) | F2NTSR1APLNRC5AR1NTSR2 | |
| SCHEMBL11023119 | 0.82 | AGTR1 (0.61) | F2NTSR1APLNRC5AR1NTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763234-B2 | Pharmaceutical compounds | GE HEALTHCARE AS (NO) | 2010-07-27 | — | — | US | disclosed |
| US-20070297979-A1 | Pharmaceutical Compounds | GE HEALTHCARE AS (NO) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070297979-A1 | Pharmaceutical Compounds | FURIN, ACE, PEPD | F2 97/4885NTSR1 804/4885APLNR 360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.